POLYPHARMACY AND POTENTIAL DRUG-DRUG INTERACTIONS IN OLDER CARDIOVASCULAR PATIENTS ACCORDING TO MEDICAL INFORMATION SYSTEM

被引：0
|
作者：
Anfinogenova, Nina [1 ]
Novikova, Oksana [1 ]
Efimova, Elena [1 ]
Maksimova, Aleksandra [1 ]
Shelkovnikova, Tatiana [1 ]
Ryumshina, Nadezhda [1 ]
Chesalov, Nazary [1 ]
Trubacheva, Irina [1 ]
Stepanov, Vadim [2 ]
Popov, Sergey [1 ]
Repin, Alexey [1 ]
机构：
[1] Russian Acad Sci, Cardiol Res Inst, Tomsk Natl Res Med Ctr, Tomsk, Russia
[2] Tomsk Natl Res Med Ctr, Res Inst Med Genet, Tomsk, Russia
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P255
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Minimal Information Model for Potential Drug-Drug Interactions
    Hochheiser, Harry
    Jing, Xia
    Garcia, Elizabeth A.
    Ayvaz, Serkan
    Sahay, Ratnesh
    Dumontier, Michel
    Banda, Juan M.
    Beyan, Oya
    Brochhausen, Mathias
    Draper, Evan
    Habiel, Sam
    Hassanzadeh, Oktie
    Herrero-Zazo, Maria
    Hocum, Brian
    Horn, John
    LeBaron, Brian
    Malone, Daniel C.
    Nytro, Oystein
    Reese, Thomas
    Romagnoli, Katrina
    Schneider, Jodi
    Zhang, Louisa
    Boyce, Richard D.
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [32] Polypharmacy and Potential Drug-Drug Interactions in Home-Dwelling Older People - A Cross-Sectional Study
    Hermann, Monica
    Carstens, Nina
    Kvinge, Lars
    Fjell, Astrid
    Wennersberg, Marianne
    Folleso, Kjersti
    Skaug, Knut
    Seiger, Ake
    Cronfalk, Berit Seiger
    Bostrom, Anne-Marie
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2021, 14 : 589 - 597
  • [33] The "iatrogenic triad": polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults
    Novaes, Priscila Horta
    da Cruz, Danielle Teles
    Lucchetti, Alessandra Lamas Granero
    Leite, Isabel Cristina Gonalves
    Lucchetti, Giancarlo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (04) : 818 - 825
  • [34] Mild polypharmacy and MCI progression in older adults: the mediation effect of drug-drug interactions
    Trevisan, Caterina
    Limongi, Federica
    Siviero, Paola
    Noale, Marianna
    Cignarella, Andrea
    Manzato, Enzo
    Sergi, Giuseppe
    Maggi, Stefania
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (01) : 49 - 56
  • [35] Analysis of Potential Drug-Drug Interactions in Medical Intensive Care Unit Patients
    Uijtendaal, Esther V.
    van Harssel, Lieke L. M.
    Hugenholtz, Gerard W. K.
    Kuck, Emile M.
    Zwart-van Rijkom, Jeannette E. F.
    Cremer, Olaf L.
    Egberts, Toine C. G.
    PHARMACOTHERAPY, 2014, 34 (03): : 213 - 219
  • [36] The Prevalence of Polypharmacy and Potential Drug-Drug Interactions among Iranian Cancer Patients: Which Patients were at Risk?
    Bazrafshani, Maliheh Sadat
    Pardakhty, Abbas
    Khandani, Behjat Kalantari
    Nasiri, Naser
    Moghaderi, Masoud
    Bazrafshani, Azam
    Mehmandoost, Soheil
    Beigzadeh, Amin
    Sharifi, Hamid
    CANCER INVESTIGATION, 2022, 40 (05) : 457 - 472
  • [37] The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
    Nusair, Mohammad B.
    Al-Azzam, Sayer, I
    Arabyat, Rasha M.
    Amawi, Haneen A.
    Alzoubi, Karem H.
    Rabah, Asma A.
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (02) : 155 - 160
  • [38] Drug-drug interactions in patients from medical services
    Sanchez Parada, L.
    Pardo Sanchez, R.
    Canadell Vilarrasa, L.
    Torrent Pou, J.
    Sanchez-Pacheco Tardon, L.
    Castillo Palomares, M. L.
    Jornet Montana, S.
    Vuelta Arce, M. F.
    Canela Subirada, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 187 - 187
  • [39] Audit of drug-drug interactions and adverse drug reactions due to polypharmacy in older cancer patients: First report from India
    Paul, Thomas
    Palatty, Princy L.
    Adnan, Mohammed
    George, Thomas
    Rao, Suresh
    Baliga, Manjeshwar S.
    INDIAN JOURNAL OF CANCER, 2020, 57 (04) : 405 - 410
  • [40] "Potential" Drug-Drug Interactions and the PICU: Should We Worry About ICU Polypharmacy?
    Bhatt-Mehta, Varsha
    PEDIATRIC CRITICAL CARE MEDICINE, 2016, 17 (05) : 470 - 472
12345